The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.

Study Overview: This clinical study aims to find out if certain proteins in urine can predict how obese patients with high blood pressure respond to two medicines, Irbesartan and Eplerenone. High blood pressure, also called hypertension, can cause heart problems. Scientists think looking at urine proteins might help doctors choose the best treatment for each person. 🧪

Study Process: Fifty adults will be given either Irbesartan or Eplerenone. Before starting, their blood pressure will be checked, and urine samples will be collected. After 8 weeks of treatment, blood pressure will be measured again to see who responded well. Researchers will study the urine samples to find proteins that might predict blood pressure changes.

• Duration: 8 weeks with two visits (start and end).
• Eligibility: Must be an untreated obese adult with certain blood pressure levels.
• Risks: Potential side effects of Irbesartan or Eplerenone.

Remember: Participation is voluntary, and your health and safety are priorities. If you are interested, discuss with your doctor to see if this study is right for you! 🌟